210 related articles for article (PubMed ID: 9918936)
21. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
22. Duck hepatitis B virus replication in primary bile duct epithelial cells.
Lee JY; Culvenor JG; Angus P; Smallwood R; Nicoll A; Locarnini S
J Virol; 2001 Aug; 75(16):7651-61. PubMed ID: 11462037
[TBL] [Abstract][Full Text] [Related]
23. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
24. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
Miller DS; Kotlarski I; Jilbert AR
Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
[TBL] [Abstract][Full Text] [Related]
25. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures.
Civitico GM; Locarnini SA
Virology; 1994 Aug; 203(1):81-9. PubMed ID: 8030288
[TBL] [Abstract][Full Text] [Related]
26. Cellular immune response of ducks to duck hepatitis B virus infection.
Vickery K; Cossart Y; Dixon R
J Med Virol; 1999 May; 58(1):19-25. PubMed ID: 10223541
[TBL] [Abstract][Full Text] [Related]
27. The effect of surgical immunomodulation on liver inflammation and clearance of DHBV infection.
Vickery K; Tohidi-Esfahani R; Pouliopoulos J; Welschinger R; Dixon R; Deva A; Cossart Y
J Med Virol; 2006 Dec; 78(12):1572-8. PubMed ID: 17063509
[TBL] [Abstract][Full Text] [Related]
28. Replication of naturally occurring woodchuck hepatitis virus deletion mutants in primary hepatocyte cultures and after transmission to naive woodchucks.
Lu M; Hilken G; Yang D; Kemper T; Roggendorf M
J Virol; 2001 Apr; 75(8):3811-8. PubMed ID: 11264370
[TBL] [Abstract][Full Text] [Related]
29. The early host innate immune response to duck hepatitis B virus infection.
Tohidi-Esfahani R; Vickery K; Cossart Y
J Gen Virol; 2010 Feb; 91(Pt 2):509-20. PubMed ID: 19846670
[TBL] [Abstract][Full Text] [Related]
30. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes].
Yao Y; Tang N; Huang A
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700
[TBL] [Abstract][Full Text] [Related]
31. Initial amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of embryonic duck hepatocytes is increased by cell cycle progression.
Borel C; Schorr O; Durand I; Zoulim F; Kay A; Trepo C; Hantz O
Hepatology; 2001 Jul; 34(1):168-79. PubMed ID: 11431748
[TBL] [Abstract][Full Text] [Related]
32. [Ultrastructural study and localization of duck hepatitis B virus in the livers of experimentally infected ducks].
Tian P
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1991 Apr; 13(2):108-11. PubMed ID: 1831706
[TBL] [Abstract][Full Text] [Related]
33. n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes.
Turin F; Borel C; Benchaib M; Kay A; Jamard C; Guguen-Guillouzo C; Trépo C; Hantz O
J Virol; 1996 May; 70(5):2691-6. PubMed ID: 8627742
[TBL] [Abstract][Full Text] [Related]
34. [Inhibition of duck hepatitis B virus DNA replication by antisense phosphorothioate oligodeoxynucleotides in vitro and in vivo].
Dong B; Shao XW; Tao PZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):25-7. PubMed ID: 12870012
[TBL] [Abstract][Full Text] [Related]
35. A splice hepadnavirus RNA that is essential for virus replication.
Obert S; Zachmann-Brand B; Deindl E; Tucker W; Bartenschlager R; Schaller H
EMBO J; 1996 May; 15(10):2565-74. PubMed ID: 8665864
[TBL] [Abstract][Full Text] [Related]
36. In vivo proliferation of hepadnavirus-infected hepatocytes induces loss of covalently closed circular DNA in mice.
Lutgehetmann M; Volz T; Köpke A; Broja T; Tigges E; Lohse AW; Fuchs E; Murray JM; Petersen J; Dandri M
Hepatology; 2010 Jul; 52(1):16-24. PubMed ID: 20578126
[TBL] [Abstract][Full Text] [Related]
37. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
[TBL] [Abstract][Full Text] [Related]
38. A new avian hepadnavirus infecting snow geese (Anser caerulescens) produces a significant fraction of virions containing single-stranded DNA.
Chang SF; Netter HJ; Bruns M; Schneider R; Frölich K; Will H
Virology; 1999 Sep; 262(1):39-54. PubMed ID: 10489339
[TBL] [Abstract][Full Text] [Related]
39. [Comparison of specific immune responses to duck hepatitis B virus in infected, immune, and uninfected ducks].
Tang N; Huang A; Guo S; Qi Z; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):166-8. PubMed ID: 11412394
[TBL] [Abstract][Full Text] [Related]
40. A quantitative competitive PCR assay for the covalently closed circular form of the duck hepatitis B virus.
Addison WR; Wong WW; Fischer KP; Tyrrell DL
Antiviral Res; 2000 Oct; 48(1):27-37. PubMed ID: 11080538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
